Results 201 to 210 of about 67,063 (322)

Knowledge of dental professionals and Dental students on bisphosphonates and bisphosphonate-associated osteonecrosis of the jaws

, 2022
Leonardo Paredes, Lúcio Souza Gonçalves, Águida Maria Menezes Aguiar Miranda, JULIANA DE NORONHA SANTOS NETTO, Danyel Elias da Cruz Pérez, Fábio Ramôa Pires   +5 more
openalex   +2 more sources

Impact of Open Proximal Contacts on Peri‐Implant Diseases: A Systematic Review and Meta‐Analysis

Clinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.
ABSTRACT Objectives The aim of this systematic review and meta‐analysis was to evaluate the impact of open proximal contacts on peri‐implant tissue changes, specifically marginal bone levels, probing pocket depth, and the incidence of peri‐implant diseases.
Momen A. Atieh, Maanas Shah, Abeer Hakam, Khaleifa Bohamedi, Andrew Tawse‐Smith, Nabeel H. M. Alsabeeha   +5 more
wiley   +1 more source

High Prevalence of Osteopenia and Osteoporosis in Total Hip and Total Knee Arthroplasty Patients and Effects of Anti-Resorptive Agents on Bone Health Optimization: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Wong RMY, Wong PY, Lee JK, Unnanuntana A, Amphansap T, Ebeling PR, Close J, Duque G, Law SW, Cheung WH.   +9 more
europepmc   +1 more source

Storage and Loss Moduli of Bone in Osteogenesis Imperfecta (OI) [PDF]

, 2012
Albert, Carolyne, Harris, Gerald F., Jameson, John, Smith, Peter A., Toth, Jeffrey   +4 more
core   +1 more source

Bisphosphonates [PDF]

Dental Press Implantology, 2015
openaire   +1 more source

Isolated Atypical Pedicle Stress Fractures in Patients on Prolonged Bisphosphonate Therapy: Report of Two Cases and a Literature-Based Proposal for Diagnostic Criteria. [PDF]

J Clin Med
Auron M, Fisher-Negev T, Barkay G, Schroeder JE.   +3 more
europepmc   +1 more source

Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment

International Journal of Cancer, Volume 158, Issue 3, Page 633-641, 1 February 2026.
What's new? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas, Sarah Hjorth, Cassia B. Trewin‐Nybråten, Giske Ursin, Edoardo Botteri, Bettina Kulle Andreassen, Kristin V. Reinertsen, Egil S. Blix, Bjørn Naume, Nathalie C. Støer   +9 more
wiley   +1 more source

Impact of Prolonged Bisphosphonate Therapy on Atypical Femoral Fractures: Insights from a Single-Center Experience. [PDF]

J Pers Med
Caldaci A, Panebianco P, Condorelli S, Zappalà N, Costarella L, Sapienza M, Testa G, Pavone V.   +7 more
europepmc   +1 more source

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Shifting bisphosphonate prescribing patterns for fracture prevention: a 24-year national surveillance of men in the U.S. Veterans Health Administration. [PDF]

Arch Osteoporos
Elam RE, Lo JC, Schousboe JT, Adler RA, Fink HA, Ott SM, Barzilay J, Weaver FM, Budde E, Huo Z, Jacob R, Carbone LD.   +11 more
europepmc   +1 more source